↓ Skip to main content

Dove Medical Press

Article Metrics

Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy

Overview of attention for article published in Vascular Health and Risk Management, February 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (74th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter
6 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
62 Mendeley
Title
Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy
Published in
Vascular Health and Risk Management, February 2017
DOI 10.2147/vhrm.s95044
Pubmed ID
Authors

Nicola Tarantino, Francesco Santoro, Luisa De Gennaro, Michele Correale, Francesca Guastafierro, Antonio Gaglione, Matteo Di Biase, Natale Daniele Brunetti

Abstract

Lipids disorder is the principal cause of atherosclerosis and may present with several forms, according to blood lipoprotein prevalence. One of the most common forms is combined dyslipidemia, characterized by high levels of triglycerides and low level of high-density lipoprotein. Single lipid-lowering drugs may have very selective effect on lipoproteins; hence, the need to use multiple therapy against dyslipidemia. However, the risk of toxicity is a concerning issue. In this review, the effect and safety of an approved combination therapy with simvastatin plus fenofibrate are described, with an analysis of pros and cons resulting from randomized multicenter trials, meta-analyses, animal models, and case reports as well.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 62 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 2%
Unknown 61 98%

Demographic breakdown

Readers by professional status Count As %
Other 10 16%
Student > Ph. D. Student 10 16%
Researcher 9 15%
Student > Bachelor 7 11%
Student > Master 6 10%
Other 11 18%
Unknown 9 15%
Readers by discipline Count As %
Medicine and Dentistry 20 32%
Pharmacology, Toxicology and Pharmaceutical Science 10 16%
Biochemistry, Genetics and Molecular Biology 5 8%
Nursing and Health Professions 4 6%
Economics, Econometrics and Finance 2 3%
Other 9 15%
Unknown 12 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 March 2020.
All research outputs
#3,235,606
of 17,175,498 outputs
Outputs from Vascular Health and Risk Management
#112
of 639 outputs
Outputs of similar age
#69,529
of 272,205 outputs
Outputs of similar age from Vascular Health and Risk Management
#2
of 11 outputs
Altmetric has tracked 17,175,498 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 639 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 272,205 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.